✦ LIBER ✦

785 Poster Accelerated fractionation with concomitant boost (AFX-C) and concurrent Cisplatin, for locally advanced, unresectable, head and neck cancer (LAHNC). Preliminary report of a phase II trial

Book ID: 119513430
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 152 KB
Volume: 64
Category: Article
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(02)83094-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of concomitant boost ra

A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas

✍ José Antonio Medina; Antonio Rueda; Antonio Sacchetti de Pasos; Jorge Contreras; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 90 KB

A phase II study of concomitant boost ra

A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas

✍ J. Contreras Martinez; J.A. Medina; P. Moreno; A. Villanueva; A. Rueda; J.M. Ric 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 470 KB

Concomitant boost radiation and concurre

Concomitant boost radiation and concurrent cisplatin for advanced head and neck carcinomas. Preliminary results of a phase II, single-institutional trial

✍ Fernando Arias de la Vega; Miguel Angel Domínguez Domínguez; Ana Manterola Burga 📂 Article 📅 2005 🏛 Springer Milan 🌐 Spanish ⚖ 122 KB

Concomitant boost radiation and concurre

Concomitant boost radiation and concurrent cisplatin for advanced head and neck carcinomas: preliminary results of a phase II trial of the RTOG (99-14)

✍ K.K Ang; J Harris; A.S Garden; C.U Jones; A Trotti; J Cheng; S.A Spencer; R.S We 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 21 KB

Docetaxel, cisplatin, and fluorouracil i

Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216)

✍ David J. Adelstein; James Moon; Ehab Hanna; P. G. Shankar Giri; Glenn M. Mills; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

## Abstract ## Background In an effort to optimize nonoperative therapy in patients with locoregionally advanced head and neck squamous cell cancer, the Southwest Oncology Group conducted a phase II trial combining 3‐drug taxane‐containing induction chemotherapy with accelerated fractionation/conc

Trismus After Chemoradiation Therapy for

Trismus After Chemoradiation Therapy for Locoregionally Advanced Head and Neck Cancer: A Prospective Study of the Dose Effect Relationship in Accelerated Fractionation by Concomitant Boost With Cisplatin and Cetuximab From the EPIC Trial

✍ Chaudhary, A.; Bair, R.J.; Bair, E.D.; Partouche, J.; Witt, M.; Villaflor, V.M.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 72 KB